These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15449406)

  • 1. Pharmacogenetic testing, informed consent and the problem of secondary information.
    Netzer C; Biller-Andorno N
    Bioethics; 2004 Aug; 18(4):344-60. PubMed ID: 15449406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and ethical considerations in pharmacogenetic testing: views of physicians in 3 "early adopting" departments of psychiatry.
    Hoop JG; Lapid MI; Paulson RM; Roberts LW
    J Clin Psychiatry; 2010 Jun; 71(6):745-53. PubMed ID: 20361898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consent and privacy in pharmacogenetic testing.
    Robertson JA
    Nat Genet; 2001 Jul; 28(3):207-9. PubMed ID: 11431685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing patients with information on pharmacogenetic testing.
    Fleeman N; Dickson R
    Nurs Stand; 2009 Jan 28-Feb 3; 23(21):46-8. PubMed ID: 19248450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacogenetics in future medical care -- implications for patients and physicians].
    Rogausch A; Brockmöller J; Himmel W
    Gesundheitswesen; 2005 Apr; 67(4):257-63. PubMed ID: 15856385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic testing: not as simple as it seems.
    Haga SB; Burke W
    Genet Med; 2008 Jun; 10(6):391-5. PubMed ID: 18496219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethical, legal and social implications of genetic testing.
    EC Expert Group
    Bull Med Ethics; 2004 Dec-2005 Jan; (204):9-11. PubMed ID: 15856582
    [No Abstract]   [Full Text] [Related]  

  • 10. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context, ethics and pharmacogenetics.
    Hedgecoe AM
    Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):566-82. PubMed ID: 16980195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging ethical issues in pharmacogenomics: from research to clinical practice.
    Freund CL; Wilfond BS
    Am J Pharmacogenomics; 2002; 2(4):273-81. PubMed ID: 12421098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consent in psychiatric biobanks for pharmacogenetic research.
    van der Baan FH; Bernabe RD; Bredenoord AL; Gregoor JG; Meynen G; Knol MJ; van Thiel GJ
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):677-82. PubMed ID: 22607776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' and physicians' perspectives on pharmacogenetic testing.
    Rogausch A; Prause D; Schallenberg A; Brockmöller J; Himmel W
    Pharmacogenomics; 2006 Jan; 7(1):49-59. PubMed ID: 16354124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ethics, politics, and rights in pharmacogenomics].
    Bellver Capella V
    Rev Derecho Genoma Hum; 2002; (17):31-55. PubMed ID: 12703107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental disorders and genetics: the ethical context: conclusions and recommendations.
    United Kingdom. Nuffield Council on Bioethics
    J Int Bioethique; 2001 Jun; 12(2):89-92. PubMed ID: 12747351
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and pitfalls in the introduction of pharmacogenetics for cancer.
    Loh M; Soong R
    Ann Acad Med Singap; 2011 Aug; 40(8):369-74. PubMed ID: 22065003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ethics of pharmacogenomics.
    Neil D; Craigie J
    Monash Bioeth Rev; 2004 Apr; 23(2):9-20. PubMed ID: 15810202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'At the point at which you can do something about it, then it becomes more relevant': informed consent in the pharmacogenetic clinic.
    Hedgecoe A
    Soc Sci Med; 2005 Sep; 61(6):1201-10. PubMed ID: 15970231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.